Abstract | BACKGROUND: METHODS: RESULTS:
Lp-PLA2 mRNA levels, protein expression and activity were significantly inhibited in response to HDL treatment in a dose and time dependent manner in human monocyte-derived macrophages. Pioglitazone treatment (1 - 10 ng/ml) upregulated the Lp-PLA2 mRNA level, protein expression and activity in human monocyte-derived macrophages, while the effects were markedly reversed by HDL. In addition, pioglitazone resulted in a significant increase in PPARγ phosphorylation in human monocyte-derived macrophages, which could be inhibited by HDL. CONCLUSION: These findings indicate that HDL suppresses the expression and activity of Lp-PLA2 in human monocyte-derived macrophages, and the underlying mechanisms may be mediated through the PPARγ pathway.
|
Authors | Guan-ping Han, Jing-yi Ren, Li Qin, Jun-xian Song, Lan Wang, Hong Chen |
Journal | Chinese medical journal
(Chin Med J (Engl))
Vol. 125
Issue 24
Pg. 4474-80
(Dec 2012)
ISSN: 2542-5641 [Electronic] China |
PMID | 23253723
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Lipoproteins, HDL
- PPAR gamma
- 1-Alkyl-2-acetylglycerophosphocholine Esterase
|
Topics |
- 1-Alkyl-2-acetylglycerophosphocholine Esterase
(genetics, metabolism)
- Cells, Cultured
- Humans
- Lipoproteins, HDL
(pharmacology)
- Macrophages
(drug effects, enzymology, metabolism)
- PPAR gamma
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction
(drug effects, genetics)
|